ClinicalTrials.gg
Not yet recruitingNCT07674108Updated Jun 29, 2026

VR Simulation-Based Implanted Port Catheter Training in Nursing Students

An interventional study of Virtual Reality Simulation-Based Implanted Port Catheter Training in Nursing Education and Clinical Competence, sponsored by Izmir Bakircay University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-29.

Sponsored by Izmir Bakircay University · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Implanted port catheter care is a critical clinical skill in oncology nursing, requiring accurate knowledge, aseptic technique, safe procedural practice, and early recognition of potential complications. This parallel group randomized controlled study aims to evaluate the effectiveness of virtual reality simulation-based implanted port catheter training in undergraduate nursing students. Eligible second-year nursing students will be randomly assigned to either an intervention group or a control group. All students will receive a two-hour traditional implanted port catheter training session in the classroom setting. In addition to traditional training, students in the intervention group will receive virtual reality simulation-based training consisting of two scenarios: safe implanted port catheter access and extravasation/complication management. The control group will receive only traditional training.

02

Conditions studied

  • Nursing Education
  • Clinical Competence

Keywords

  • Virtual reality
  • Simulation-based education
  • Implanted port catheter
  • Clinical skills
  • Nursing students
03

In context

Lead sponsor

Izmir Bakircay University is the lead sponsor of 76 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older
  • Being an undergraduate nursing student
  • Having completed the Internal Medicine Nursing course
  • Voluntarily agreeing to participate in the study
  • Providing written

Exclusion criteria

Exclusion Criteria:

  • Having any communication barrier that may prevent participation in the study or completion of the study forms
  • Having neck pain or neck injury severe enough to prevent head movement
  • Having a visual problem that prevents safe use of the virtual reality application
  • Experiencing severe nausea or dizziness during the virtual reality application
  • Having a diagnosed history of epilepsy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Virtual Reality Simulation-Based Implanted Port Catheter Training Group

    Nursing students in this group will receive a two-hour traditional implanted port catheter training session in the classroom setting. In addition to traditional training, they will receive virtual reality simulation-based implanted port catheter training consisting of two structured scenarios: safe implanted port catheter access and extravasation/complication management.

    Behavioral: Virtual Reality Simulation-Based Implanted Port Catheter Training

  • No intervention
    Control Group

    Nursing students in this group will receive only a two-hour traditional implanted port catheter training session in the classroom setting. They will not receive virtual reality simulation-based training.

Interventions

  • BehavioralVirtual Reality Simulation-Based Implanted Port Catheter Training

    The virtual reality simulation-based implanted port catheter training will be provided in addition to traditional classroom-based training. The VR training will be delivered individually using a Meta Quest 3 headset and will consist of two structured scenarios. The first scenario will focus on safe implanted port catheter access, line verification, flushing, dressing, and documentation. The second scenario will focus on recognition and management of suspected extravasation or related complications during an ongoing infusion. Each scenario is expected to last approximately 10 minutes, with a total VR training duration of approximately 20 minutes. The VR system will provide an interactive, standardized, and repeatable learning environment and will generate performance indicators related to students' procedural steps, critical errors, and complication management decisions.

06

What researchers measure

Primary outcomes

  1. Change in Implanted Port Catheter Knowledge Assessment Checklist Score

    The primary outcome is the change in students' implanted port catheter knowledge score from baseline to immediately after training. Knowledge will be assessed using the Structured Implanted Port Catheter Knowledge Assessment Checklist. The outcome will be evaluated by comparing the change in knowledge score from baseline to after training between the intervention and control groups. Higher scores indicate a higher level of knowledge regarding implanted port catheter care and application.

    Time frame: Baseline, pre-intervention; immediately after the intervention

  2. Change in Student Satisfaction and Self-Confidence in Learning Scale Score

    Students' satisfaction and self-confidence related to the learning experience will be assessed after the intervention using the Student Satisfaction and Self-Confidence in Learning Scale. The satisfaction-related score will be compared between the intervention and control groups. Higher scores indicate higher levels of satisfaction and self-confidence in learning.

    Time frame: Baseline, pre-intervention; immediately after the intervention

  3. Change in Instructional Materials Motivation Survey Score

    Nursing students' motivation toward the instructional material will be assessed baseline and after training using the Instructional Materials Motivation Scale. Motivation scores will be compared between the intervention and control groups. Higher scores indicate higher motivation toward the instructional material.

    Time frame: Baseline, pre-intervention; immediately after the intervention

Secondary outcomes

  1. Implanted Port Catheter Application Performance Score

    The implanted port catheter application performance score will be assessed only in the intervention group during the virtual reality simulation session. This score will be generated by the virtual reality system and will include performance indicators related to routine implanted port catheter application and extravasation/complication management. The score will reflect students' completion of procedural steps, critical safety actions, errors, and complication management decisions during the VR scenarios. This outcome will be analyzed as an intervention-group-specific secondary process outcome and will not be used for between-group effectiveness comparison because the control group will not be exposed to the virtual reality simulation environment. Higher scores indicate better implanted port catheter application performance in the VR simulation environment.

    Time frame: During the virtual reality simulation session, immediately after completion of each VR scenario

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Jan 2027, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 21, 2026
First posted
Jun 29, 2026
StartEst.
Sep 21, 2026
Primary completionEst.
Jan 4, 2027
CompletionEst.
Jun 28, 2027
Last update
Jun 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07674108
Lead sponsor
Izmir Bakircay University
Responsible party
Pinar Zorba Bahceli, PhD RN (Associate Professor, Izmir Bakircay University) — Principal investigator
First posted
Jun 29, 2026
Start date
Sep 21, 2026 (estimated)
Primary completion
Jan 4, 2027 (estimated)
Completion
Jun 28, 2027 (estimated)
Last update
Jun 29, 2026

Study contacts

Pinar Zorba Bahceli, PhD
Contact
pinarzorba85@gmail.com
+90 553 487 25 50
Hasan Onur Duman, RN
Contact
6010036@bakircay.edu.tr
+90 534 449 88 83

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion